Medicamen Biotech (BOM:531146) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531146 Medicamen Biotech Ltd BOM:531146
58 GF Score
Price ₹238.45
GF Value ₹510.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Medicamen Biotech Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:531146 vs ZTS: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Biotech's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicamen Biotech Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Biotech's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Medicamen Biotech's Short Percentage of Float falls into.


BOM:531146
58GF Score
Medicamen Biotech Ltd BOM:531146
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicamen Biotech (BOM:531146) Overvalued in 2026?

Based on GuruFocus' analysis, Medicamen Biotech stock appears to be undervalued. The current stock price of ₹238.45 is trading 53.3% below its estimated GF Value™ of ₹510.73. GuruFocus considers Medicamen Biotech to be Possible Value Trap.

Key valuation signals for BOM:531146:

  • Short Percentage of Float:
  • GF Value™: ₹510.73 vs. price of ₹238.45 (53.3% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the BOM:531146 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicamen Biotech Business Description

Other Exchanges MEDICAMEQ:India
Address 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. It generates revenue from the sale of pharmaceutical products.
58GF Score

Get the complete analysis for BOM:531146

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹238.45
Price
₹510.73
GF Value